The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we have an investigator that's been funded by The milen Institute that is looking at the role of acromania in bipolar disorder I mean that's kind of amazing if you really think about it so you've got basically a dozen piis around the world on the basis of one you know relatively small pilot study that was very well done published in a very well a very reputable journal and that alone has generated that much interest
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.